LKM INNOVATIONS LIMITED

• ⚠

  Material uncertainty over going concern

  During 2025, the directors resolved to wind down the remaining business within the company and transfer all remaining assets and liabilities to Roche Diagnostics Limited, its parent company. While the company will continue to receive support from the wider group throughout this transitional period, the decision to cease trading activities has been formally approved. Accordingly, the financial statements have not been prepared on a going concern basis.

• ◆

  3 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

• ◆

  1 PSC ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -87.2%

  £248,995 → £31,760

• Cash

  -38.1%

  £20,494 → £12,691

  lowest in 5 filed years

• Net assets

  +1.6%

  £554,066 → £563,198

• Employees

  -33.3%

  6 → 4

• Operating profit

  +335.4%

  -£642 → £1,511

• Profit before tax

  +70.5%

  £5,356 → £9,132

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. LKM INNOVATIONS LIMITED 2022-03-16 → present
2. LUMIRADX TECHNOLOGY LTD 2016-06-02 → 2022-03-16
3. MULTI-SENSE TECHNOLOGIES LIMITED 2009-10-29 → 2016-06-02

Accounting basis

IFRS

Reporting scope

Standalone (parent only)

Auditor

Johnston Carmichael LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“During 2025, the directors resolved to wind down the remaining business within the company and transfer all remaining assets and liabilities to Roche Diagnostics Limited, its parent company. While the company will continue to receive support from the wider group throughout this transitional period, the decision to cease trading activities has been formally approved. Accordingly, the financial statements have not been prepared on a going concern basis.”

Significant events

• “During 2025, the directors resolved to wind down the remaining business within the company and transfer all remaining assets and liabilities to Roche Diagnostics Limited, its parent company. While the company will continue to receive support from the wider group throughout this transitional period, the decision to cease trading activities has been formally approved.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

2

last 24 months

Officers appointed

0

last 12 months

Officers resigned

3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.